Mosaic ImmunoEngineering Inc (CPMV)
0.40
+0.01
(+2.56%)
USD |
OTCM |
May 17, 16:00
Mosaic ImmunoEngineering Max Drawdown (5Y): 97.57% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 97.57% |
March 31, 2024 | 97.57% |
February 29, 2024 | 97.57% |
January 31, 2024 | 97.57% |
December 31, 2023 | 97.57% |
November 30, 2023 | 97.57% |
October 31, 2023 | 97.57% |
September 30, 2023 | 97.57% |
August 31, 2023 | 97.57% |
July 31, 2023 | 97.57% |
June 30, 2023 | 97.57% |
May 31, 2023 | 97.57% |
April 30, 2023 | 97.95% |
March 31, 2023 | 98.05% |
February 28, 2023 | 98.05% |
January 31, 2023 | 98.05% |
December 31, 2022 | 98.16% |
November 30, 2022 | 98.16% |
October 31, 2022 | 98.16% |
September 30, 2022 | 98.16% |
August 31, 2022 | 98.16% |
July 31, 2022 | 98.16% |
June 30, 2022 | 98.16% |
May 31, 2022 | 98.16% |
April 30, 2022 | 98.16% |
Date | Value |
---|---|
March 31, 2022 | 98.16% |
February 28, 2022 | 98.16% |
January 31, 2022 | 98.16% |
December 31, 2021 | 98.16% |
November 30, 2021 | 98.16% |
October 31, 2021 | 98.42% |
September 30, 2021 | 98.46% |
August 31, 2021 | 98.46% |
July 31, 2021 | 98.46% |
June 30, 2021 | 98.46% |
May 31, 2021 | 98.46% |
April 30, 2021 | 98.46% |
March 31, 2021 | 98.46% |
February 28, 2021 | 98.46% |
January 31, 2021 | 98.46% |
December 31, 2020 | 98.46% |
November 30, 2020 | 98.46% |
October 31, 2020 | 98.46% |
September 30, 2020 | 98.46% |
August 31, 2020 | 98.46% |
July 31, 2020 | 98.46% |
June 30, 2020 | 98.46% |
May 31, 2020 | 98.46% |
April 30, 2020 | 98.46% |
March 31, 2020 | 98.46% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.57%
Minimum
May 2023
98.46%
Maximum
May 2019
98.18%
Average
98.29%
Median
Max Drawdown (5Y) Benchmarks
Oncotelic Therapeutics Inc | 94.86% |
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -23.68 |
Beta (5Y) | 0.0671 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 170.4% |
Historical Sharpe Ratio (5Y) | -0.1346 |
Historical Sortino (5Y) | -0.4675 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.48% |